{"gene":"NDUFA9","run_date":"2026-04-29T11:37:56","timeline":{"discoveries":[{"year":2008,"finding":"SIRT3, the mitochondrial NAD-dependent deacetylase, physically interacts with NDUFA9 (the 39-kDa Complex I subunit) and deacetylates multiple Complex I components; loss of SIRT3 increases acetylation of Complex I subunits and selectively inhibits Complex I activity, while exogenous SIRT3 augments Complex I activity, establishing NDUFA9 as a SIRT3 substrate/interactor that links protein acetylation to Complex I regulation.","method":"Co-immunoprecipitation of SIRT3 with NDUFA9; reconstitution with wild-type vs. deacetylase-deficient SIRT3 in Sirt3-/- MEFs; measurement of Complex I activity and ATP levels in knockout mice tissues","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP plus functional rescue with catalytic mutant, replicated across cell and animal models","pmids":["18794531"],"is_preprint":false},{"year":2011,"finding":"A homozygous missense mutation in NDUFA9 (Arg321Pro) causes neonatally fatal Leigh syndrome with Complex I deficiency; lentiviral complementation with wild-type but not mutant NDUFA9 restored Complex I activity in patient fibroblasts, establishing NDUFA9 as an essential structural/functional subunit of Complex I whose integrity is required for Complex I activity.","method":"Homozygosity mapping; functional complementation with wild-type vs. mutant NDUFA9 via lentiviral transduction; Complex I enzyme activity assay in patient fibroblasts","journal":"Journal of medical genetics","confidence":"High","confidence_rationale":"Tier 2 — loss-of-function patient cells with defined biochemical phenotype rescued by wild-type but not mutant protein","pmids":["22114105"],"is_preprint":false},{"year":2012,"finding":"TALEN-mediated knockout of NDUFA9 in HEK293T cells demonstrated that NDUFA9 is required for stabilizing the junction between the membrane arm and matrix arm of Complex I; cells lacking NDUFA9 accumulated a membrane arm subcomplex but lacked matrix arm marker subunits, and re-expression of NDUFA9 restored full Complex I assembly, identifying NDUFA9's role as a late assembly step critical for Complex I biogenesis.","method":"TALEN-mediated gene knockout; Blue-Native PAGE and immunoblotting of Complex I subcomplexes; galactose growth assay; rescue by re-expression of NDUFA9","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — clean biallelic KO with defined subcomplexes identified and rescued by re-expression; multiple orthogonal readouts","pmids":["23223238"],"is_preprint":false},{"year":2016,"finding":"Systematic knockout of all 31 accessory subunits of human Complex I confirmed NDUFA9 as strictly required for assembly of a functional Complex I; proteomic analysis showed that loss of NDUFA9 destabilizes subunits within the same Q-module structural module.","method":"CRISPR/Cas9 gene editing of each accessory subunit; quantitative proteomic analysis (TMT-based MS); Blue-Native PAGE","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 — genome-wide systematic KO screen with quantitative proteomics, strong mechanistic resolution at module level","pmids":["27626371"],"is_preprint":false},{"year":2017,"finding":"Cryo-EM structure of the human respiratory megacomplex I2III2IV2 enabled precise subunit assignment within Complex I, including NDUFA9 as part of the Q-module at the junction between the peripheral matrix arm and the membrane arm.","method":"Single-particle cryo-electron microscopy of purified human megacomplex I2III2IV2","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1 — high-resolution cryo-EM structure with individual subunit assignment","pmids":["28844695"],"is_preprint":false},{"year":2017,"finding":"Patient fibroblast studies with two different NDUFA9 missense variants showed that NDUFA9 is a Q-module subunit whose dysfunction causes accumulation of Q-module subassemblies; the more severe variant additionally caused P-module subassembly accumulation, demonstrating that the severity of the NDUFA9 variant correlates with the extent of Complex I assembly disruption. Lentiviral complementation with wild-type NDUFA9 rescued both Complex I deficiency and assembly defects.","method":"Patient fibroblast BN-PAGE complex I assembly analysis; lentiviral complementation with wild-type NDUFA9; exome sequencing for variant identification","journal":"Clinical genetics","confidence":"High","confidence_rationale":"Tier 2 — two independent patient alleles with assembly sub-complex characterization and functional rescue","pmids":["28671271"],"is_preprint":false},{"year":2024,"finding":"NDUFA9 promotes browning of white adipocytes by enhancing mitochondrial Complex I activity, ATP synthesis, and mitochondrial respiration; crotonylation of NDUFA9 (induced by SAHA + sodium crotonate treatment) promotes white adipocyte browning, whereas acetylation of NDUFA9 inhibits this process, revealing a competition between these two PTMs as a regulatory switch for NDUFA9 function in adipocyte thermogenesis.","method":"NDUFA9 overexpression/knockdown in white adipocyte cell lines; SAHA + sodium crotonate or SAHA + sodium acetate treatment; measurement of mitochondrial Complex I activity, OCR, ATP production; in vivo fat browning mouse model","journal":"The international journal of biochemistry & cell biology","confidence":"Medium","confidence_rationale":"Tier 2/3 — single lab with multiple functional readouts but PTM mechanism relies on pharmacological induction without site-specific mutagenesis","pmids":["38657899"],"is_preprint":false},{"year":2025,"finding":"Functional studies in fibroblasts from individuals with biallelic NDUFA9 variants showed loss of fully assembled Complex I, decreased steady-state NDUFA9 protein levels, and/or reduced Complex I activity; protein structural modelling indicated that pathogenic variants cause NDUFA9 misfolding and/or disruption of binding interfaces, with Arg360 identified as a mutational hotspot critical for protein stability/interactions.","method":"Patient fibroblast Complex I activity assay; BN-PAGE steady-state assembly analysis; in silico protein structural modelling of variant effects","journal":"Brain communications","confidence":"Medium","confidence_rationale":"Tier 2 — functional fibroblast data from multiple patients; structural modelling is computational (Tier 4) but fibroblast biochemistry provides Tier 2 anchor","pmids":["41069424"],"is_preprint":false},{"year":2026,"finding":"YY1 transcription factor directly binds the NDUFA9 promoter and drives its transcriptional upregulation in NSCLC; NDUFA9 depletion impairs mitochondrial Complex I activity, reduces oxygen consumption and ATP production, increases ROS, and suppresses Akt-mTOR signalling, while NDUFA9 overexpression enhances mitochondrial function and promotes Akt-mTOR activation, placing NDUFA9 as a positive regulator coupling mitochondrial metabolism to the Akt-mTOR pathway in cancer cells.","method":"ChIP and luciferase reporter assays for YY1-NDUFA9 promoter binding; shRNA/CRISPR KO and overexpression in NSCLC cells; measurement of OCR, Complex I activity, ATP, ROS, mitochondrial membrane potential, mtDNA; phospho-immunoblotting of Akt/S6K/mTOR; xenograft mouse tumour model","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal methods in single lab with in vivo validation; YY1 binding validated by ChIP","pmids":["42014681"],"is_preprint":false}],"current_model":"NDUFA9 is a Q-module accessory subunit of mitochondrial respiratory chain Complex I that is essential for stabilizing the junction between the membrane arm and matrix arm during late-stage Complex I assembly; it is a direct binding partner and substrate of the deacetylase SIRT3, whose activity promotes Complex I function, and its activity is further modulated by competing crotonylation (activating) and acetylation (inhibitory) modifications; transcriptionally, YY1 drives NDUFA9 expression, and NDUFA9 in turn sustains Akt-mTOR signalling by supporting mitochondrial ATP production and Complex I activity."},"narrative":{"teleology":[{"year":2008,"claim":"Identifying SIRT3 as a direct NDUFA9 interactor and deacetylase established that reversible lysine acetylation regulates Complex I activity, linking NAD⁺-dependent signalling to oxidative phosphorylation.","evidence":"Co-immunoprecipitation of SIRT3 with NDUFA9; Complex I activity and ATP measurements in Sirt3-knockout MEFs and tissues with wild-type vs. catalytically dead SIRT3 rescue","pmids":["18794531"],"confidence":"High","gaps":["Specific NDUFA9 lysine residues targeted by SIRT3 were not mapped","Whether SIRT3-mediated deacetylation affects Complex I assembly or only catalytic activity was not resolved"]},{"year":2011,"claim":"Discovery that a homozygous NDUFA9 missense variant (Arg321Pro) causes fatal Leigh syndrome with isolated Complex I deficiency proved that NDUFA9 integrity is essential for Complex I function in humans.","evidence":"Homozygosity mapping in a consanguineous family; lentiviral wild-type vs. mutant NDUFA9 complementation in patient fibroblasts with Complex I activity rescue","pmids":["22114105"],"confidence":"High","gaps":["Mechanism by which the Arg321Pro substitution disrupts Complex I was not determined at structural level","Whether residual Complex I assembly persists in patient cells was not characterized"]},{"year":2012,"claim":"TALEN-mediated knockout revealed that NDUFA9 acts at a late assembly step, stabilizing the junction between the membrane and matrix arms of Complex I — cells lacking NDUFA9 accumulate an incomplete membrane-arm subcomplex.","evidence":"Biallelic NDUFA9 KO in HEK293T; BN-PAGE subcomplex profiling; galactose growth assay; rescue by NDUFA9 re-expression","pmids":["23223238"],"confidence":"High","gaps":["The precise molecular contacts through which NDUFA9 bridges the two arms were not resolved","Whether NDUFA9 loss also affects supercomplex formation was not tested"]},{"year":2016,"claim":"A systematic CRISPR screen of all 31 accessory subunits confirmed NDUFA9 as strictly essential and assigned it to the Q-module, showing that its loss destabilises co-modular subunits.","evidence":"CRISPR/Cas9 KO of each accessory subunit in HEK293T; TMT-based quantitative proteomics; BN-PAGE","pmids":["27626371"],"confidence":"High","gaps":["Order of NDUFA9 incorporation relative to other Q-module subunits during assembly was not resolved"]},{"year":2017,"claim":"High-resolution cryo-EM of the human respiratory megacomplex provided the first atomic-level view of NDUFA9 within the Q-module, confirming its position at the membrane-matrix arm interface and enabling rationalisation of disease mutations.","evidence":"Single-particle cryo-EM of purified human megacomplex I₂III₂IV₂","pmids":["28844695"],"confidence":"High","gaps":["Dynamic conformational changes of NDUFA9 during the catalytic cycle (A/D transition) were not captured"]},{"year":2017,"claim":"Analysis of two additional patient NDUFA9 alleles demonstrated that variant severity correlates with the degree of Complex I assembly disruption, extending the genotype-phenotype relationship and confirming Q-module subassembly accumulation as a diagnostic signature.","evidence":"BN-PAGE assembly profiling and lentiviral rescue in fibroblasts from patients with two distinct NDUFA9 missense variants","pmids":["28671271"],"confidence":"High","gaps":["Threshold level of residual NDUFA9 function compatible with survival was not defined"]},{"year":2024,"claim":"Demonstration that crotonylation activates and acetylation inhibits NDUFA9 function in adipocytes revealed a PTM-based switch controlling Complex I-dependent thermogenesis, extending the regulatory framework beyond SIRT3-mediated deacetylation.","evidence":"NDUFA9 overexpression/knockdown in white adipocytes; pharmacological induction of crotonylation vs. acetylation; OCR, ATP, and Complex I activity measurements; in vivo browning model","pmids":["38657899"],"confidence":"Medium","gaps":["Specific crotonylated and acetylated lysine sites on NDUFA9 were not identified by site-directed mutagenesis","Whether these PTMs alter NDUFA9 assembly into Complex I or only its catalytic contribution is unknown","Results rely on pharmacological PTM induction rather than site-specific modification"]},{"year":2025,"claim":"Expanded patient cohort analysis with structural modelling identified Arg360 as a mutational hotspot and showed that pathogenic variants cause NDUFA9 misfolding or disruption of inter-subunit binding interfaces, providing a structural rationale for disease severity.","evidence":"Patient fibroblast BN-PAGE and Complex I activity assays; in silico protein structural modelling of multiple NDUFA9 variants","pmids":["41069424"],"confidence":"Medium","gaps":["Structural predictions have not been validated by experimental structure determination of mutant forms","Functional rescue with site-directed mutants of Arg360 was not performed"]},{"year":2026,"claim":"Identification of YY1 as a direct transcriptional activator of NDUFA9 and demonstration that NDUFA9 depletion suppresses Akt-mTOR signalling placed NDUFA9 as a node coupling mitochondrial ATP output to growth-factor signalling in cancer cells.","evidence":"ChIP and luciferase reporter assays for YY1 binding; NDUFA9 KD/KO and overexpression in NSCLC lines; OCR, ATP, ROS, phospho-Akt/S6K immunoblotting; xenograft model","pmids":["42014681"],"confidence":"Medium","gaps":["Whether YY1-driven NDUFA9 expression is relevant outside NSCLC contexts is untested","Whether the Akt-mTOR effect is specific to NDUFA9 or a general consequence of Complex I deficiency is not distinguished"]},{"year":null,"claim":"Key open questions include the identity and functional impact of specific NDUFA9 lysine residues modified by SIRT3, crotonylation, and acetylation; the conformational dynamics of NDUFA9 during the active/deactive transition of Complex I; and whether NDUFA9 has roles beyond Complex I (e.g. in supercomplex organisation or signalling).","evidence":"","pmids":[],"confidence":"Low","gaps":["No site-specific mutagenesis of individual PTM sites has been performed","Conformational dynamics of NDUFA9 during the A/D transition remain unresolved","Potential scaffolding or signalling functions independent of Complex I catalysis have not been investigated"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[2,3,4,5]}],"localization":[{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[0,1,2,3,4,5,6,7,8]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[0,1,2,3,6,8]},{"term_id":"R-HSA-1852241","term_label":"Organelle biogenesis and maintenance","supporting_discovery_ids":[2,3,5]}],"complexes":["Complex I (NADH:ubiquinone oxidoreductase)","Respiratory megacomplex I2III2IV2"],"partners":["SIRT3","YY1"],"other_free_text":[]},"mechanistic_narrative":"NDUFA9 is an accessory subunit of mitochondrial respiratory chain Complex I that occupies the Q-module at the junction between the peripheral matrix arm and the membrane arm, where it is indispensable for late-stage Complex I assembly and activity. TALEN- and CRISPR-mediated knockout studies show that loss of NDUFA9 causes accumulation of incomplete membrane-arm subcomplexes while preventing incorporation of matrix-arm subunits, and re-expression rescues full Complex I assembly and oxidative phosphorylation [PMID:23223238, PMID:27626371]. NDUFA9 is a direct substrate of the mitochondrial deacetylase SIRT3, and its activity is further modulated by competing crotonylation (activating) and acetylation (inhibitory) post-translational modifications that tune Complex I function in contexts such as adipocyte thermogenesis [PMID:18794531, PMID:38657899]. Biallelic loss-of-function mutations in NDUFA9 cause Leigh syndrome with isolated Complex I deficiency [PMID:22114105, PMID:28671271]."},"prefetch_data":{"uniprot":{"accession":"Q16795","full_name":"NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial","aliases":["Complex I-39kD","CI-39kD","NADH-ubiquinone oxidoreductase 39 kDa subunit"],"length_aa":377,"mass_kda":42.5,"function":"Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis. Required for proper complex I assembly (PubMed:28671271). Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone","subcellular_location":"Mitochondrion matrix","url":"https://www.uniprot.org/uniprotkb/Q16795/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/NDUFA9","classification":"Not Classified","n_dependent_lines":337,"n_total_lines":1208,"dependency_fraction":0.27897350993377484},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/NDUFA9","total_profiled":1310},"omim":[{"mim_id":"618251","title":"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31","url":"https://www.omim.org/entry/618251"},{"mim_id":"618247","title":"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26","url":"https://www.omim.org/entry/618247"},{"mim_id":"615898","title":"NADH DEHYDROGENASE (UBIQUINONE) COMPLEX I, ASSEMBLY FACTOR 7; NDUFAF7","url":"https://www.omim.org/entry/615898"},{"mim_id":"615534","title":"TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE DOMAIN-CONTAINING PROTEIN 1; TIMMDC1","url":"https://www.omim.org/entry/615534"},{"mim_id":"614919","title":"NITRIC OXIDE-ASSOCIATED PROTEIN 1; NOA1","url":"https://www.omim.org/entry/614919"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Mitochondria","reliability":"Approved"},{"location":"Nucleoplasm","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/NDUFA9"},"hgnc":{"alias_symbol":["SDR22E1","CI-39k","COQ11"],"prev_symbol":["NDUFS2L"]},"alphafold":{"accession":"Q16795","domains":[{"cath_id":"3.40.50.720","chopping":"40-204","consensus_level":"medium","plddt":95.9328,"start":40,"end":204},{"cath_id":"3.90.25","chopping":"209-238_269-331_344-377","consensus_level":"medium","plddt":93.6212,"start":209,"end":377}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q16795","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q16795-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q16795-F1-predicted_aligned_error_v6.png","plddt_mean":89.62},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=NDUFA9","jax_strain_url":"https://www.jax.org/strain/search?query=NDUFA9"},"sequence":{"accession":"Q16795","fasta_url":"https://rest.uniprot.org/uniprotkb/Q16795.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q16795/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q16795"}},"corpus_meta":[{"pmid":"23223238","id":"PMC_23223238","title":"Gene knockout using transcription activator-like effector nucleases (TALENs) reveals that human NDUFA9 protein is essential for stabilizing the junction between membrane and matrix arms of complex I.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23223238","citation_count":68,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25631044","id":"PMC_25631044","title":"Identification of Coq11, a new coenzyme Q biosynthetic protein in the CoQ-synthome in Saccharomyces cerevisiae.","date":"2015","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25631044","citation_count":64,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22114105","id":"PMC_22114105","title":"Defective NDUFA9 as a novel cause of neonatally fatal complex I disease.","date":"2011","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22114105","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28671271","id":"PMC_28671271","title":"NDUFA9 point mutations cause a variable mitochondrial complex I assembly defect.","date":"2017","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28671271","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32205446","id":"PMC_32205446","title":"COQ11 deletion mitigates respiratory deficiency caused by mutations in the gene encoding the coenzyme Q chaperone protein Coq10.","date":"2020","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/32205446","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35892093","id":"PMC_35892093","title":"HIV-1 Tat and cocaine impact astrocytic energy reservoirs and epigenetic regulation by influencing the LINC01133-hsa-miR-4726-5p-NDUFA9 axis.","date":"2022","source":"Molecular therapy. Nucleic acids","url":"https://pubmed.ncbi.nlm.nih.gov/35892093","citation_count":10,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38657899","id":"PMC_38657899","title":"NDUFA9 and its crotonylation modification promote browning of white adipocytes by activating mitochondrial function in mice.","date":"2024","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/38657899","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37156397","id":"PMC_37156397","title":"Identification of novel coenzyme Q10 biosynthetic proteins Coq11 and Coq12 in Schizosaccharomyces pombe.","date":"2023","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/37156397","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41069424","id":"PMC_41069424","title":"Biallelic NDUFA9 variants cause a progressive neurodevelopmental disorder with prominent dystonia and mitochondrial complex I deficiency.","date":"2025","source":"Brain communications","url":"https://pubmed.ncbi.nlm.nih.gov/41069424","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"42014681","id":"PMC_42014681","title":"YY1-mediated NDUFA9 upregulation promotes NSCLC cell growth through mitochondrial and Akt-mTOR pathway modulation.","date":"2026","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/42014681","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18794531","id":"PMC_18794531","title":"A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis.","date":"2008","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/18794531","citation_count":1078,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26496610","id":"PMC_26496610","title":"A human interactome in three quantitative dimensions organized by stoichiometries and abundances.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26496610","citation_count":1015,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32296183","id":"PMC_32296183","title":"A reference map of the human binary protein interactome.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32296183","citation_count":849,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19490893","id":"PMC_19490893","title":"A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene.","date":"2009","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/19490893","citation_count":843,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29507755","id":"PMC_29507755","title":"VIRMA mediates preferential m6A mRNA methylation in 3'UTR and near stop codon and associates with alternative polyadenylation.","date":"2018","source":"Cell discovery","url":"https://pubmed.ncbi.nlm.nih.gov/29507755","citation_count":829,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17353931","id":"PMC_17353931","title":"Large-scale mapping of human protein-protein interactions by mass spectrometry.","date":"2007","source":"Molecular systems biology","url":"https://pubmed.ncbi.nlm.nih.gov/17353931","citation_count":733,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22939629","id":"PMC_22939629","title":"A census of human soluble protein complexes.","date":"2012","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/22939629","citation_count":689,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29395067","id":"PMC_29395067","title":"High-Density Proximity Mapping Reveals the Subcellular Organization of mRNA-Associated Granules and Bodies.","date":"2018","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/29395067","citation_count":580,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"27626371","id":"PMC_27626371","title":"Accessory subunits are integral for assembly and function of human mitochondrial complex I.","date":"2016","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/27626371","citation_count":450,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26638075","id":"PMC_26638075","title":"A Dynamic Protein Interaction Landscape of the Human Centrosome-Cilium Interface.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26638075","citation_count":433,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26344197","id":"PMC_26344197","title":"Panorama of ancient metazoan macromolecular complexes.","date":"2015","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/26344197","citation_count":407,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28844695","id":"PMC_28844695","title":"Architecture of Human Mitochondrial Respiratory Megacomplex I2III2IV2.","date":"2017","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/28844695","citation_count":391,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8012384","id":"PMC_8012384","title":"Purification of CpG islands using a methylated DNA binding column.","date":"1994","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8012384","citation_count":363,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"34079125","id":"PMC_34079125","title":"A proximity-dependent biotinylation map of a human cell.","date":"2021","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/34079125","citation_count":339,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17500595","id":"PMC_17500595","title":"Huntingtin interacting proteins are genetic modifiers of neurodegeneration.","date":"2007","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17500595","citation_count":325,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19027726","id":"PMC_19027726","title":"The SDR (short-chain dehydrogenase/reductase and related enzymes) nomenclature initiative.","date":"2008","source":"Chemico-biological interactions","url":"https://pubmed.ncbi.nlm.nih.gov/19027726","citation_count":315,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"27342126","id":"PMC_27342126","title":"Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics.","date":"2016","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/27342126","citation_count":306,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"34800366","id":"PMC_34800366","title":"Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context.","date":"2021","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/34800366","citation_count":239,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"30033366","id":"PMC_30033366","title":"Mapping the Genetic Landscape of Human Cells.","date":"2018","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/30033366","citation_count":225,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17207965","id":"PMC_17207965","title":"hORFeome v3.1: a resource of human open reading frames representing over 10,000 human genes.","date":"2007","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/17207965","citation_count":222,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"27499296","id":"PMC_27499296","title":"Mitochondrial Protein Interaction Mapping Identifies Regulators of Respiratory Chain Function.","date":"2016","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/27499296","citation_count":220,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"27173435","id":"PMC_27173435","title":"An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.","date":"2016","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/27173435","citation_count":211,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26618866","id":"PMC_26618866","title":"∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis.","date":"2015","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/26618866","citation_count":209,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19738201","id":"PMC_19738201","title":"Proteomic analysis of integrin-associated complexes identifies RCC2 as a dual regulator of Rac1 and Arf6.","date":"2009","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/19738201","citation_count":207,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":6701,"output_tokens":1467,"usd":0.021054},"stage2":{"model":"claude-opus-4-6","input_tokens":4703,"output_tokens":1956,"usd":0.108622},"total_usd":0.318433,"stage1_batch_id":"msgbatch_012ZiiCUBfB62NCTQd4Bk1Jo","stage2_batch_id":"msgbatch_01Xuqq9aUHoQouS7UVGZNStZ","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":18548,"output_tokens":2480,"usd":0.046422},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":6033,"output_tokens":2589,"usd":0.142335}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2012,\n      \"finding\": \"NDUFA9 knockout in HEK293T cells causes accumulation of a complex I subcomplex containing membrane arm subunits but lacking matrix arm marker subunits, demonstrating that NDUFA9 is required to stabilize the junction between the membrane and matrix arms of complex I as a late assembly step.\",\n      \"method\": \"TALEN-mediated gene knockout, blue native PAGE, re-expression complementation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined molecular phenotype, rescued by wild-type re-expression, multiple orthogonal methods\",\n      \"pmids\": [\"23223238\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"A pathogenic missense mutation (R321P) in NDUFA9 causes complex I deficiency; lentiviral transduction with wild-type but not mutant NDUFA9 restored complex I activity in patient fibroblasts, establishing NDUFA9 as a functionally essential complex I subunit.\",\n      \"method\": \"Homozygosity mapping, lentiviral complementation with wild-type vs. mutant NDUFA9 in patient fibroblasts, complex I activity assay\",\n      \"journal\": \"Journal of medical genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — functional complementation with mutant vs. wild-type, confirmed causal role\",\n      \"pmids\": [\"22114105\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"NDUFA9 is a Q-module subunit of complex I; patient fibroblasts with NDUFA9 variants show accumulation of Q-module subassemblies (and in severe cases, P-module subassemblies), and lentiviral wild-type NDUFA9 complementation rescues both complex I deficiency and the assembly defects, defining its role in Q-module biogenesis.\",\n      \"method\": \"Blue native PAGE assembly analysis in patient fibroblasts, lentiviral complementation\",\n      \"journal\": \"Clinical genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — orthogonal assembly analysis and complementation across two independent patients\",\n      \"pmids\": [\"28671271\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"NDUFA9 crotonylation promotes browning of white adipocytes by enhancing mitochondrial complex I activity, ATP synthesis, and mitochondrial respiration, whereas NDUFA9 acetylation inhibits white adipocyte browning; crotonylation and acetylation compete at the same sites on NDUFA9.\",\n      \"method\": \"Overexpression with SAHA+sodium crotonate or SAHA+sodium acetate treatment in adipocytes, mitochondrial complex I activity assay, oxygen consumption rate measurement, white fat browning model mice\",\n      \"journal\": \"The international journal of biochemistry & cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2/3 — in vitro and in vivo cellular assays with functional readouts, single lab, moderate mechanistic depth\",\n      \"pmids\": [\"38657899\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Protein modelling of disease-associated NDUFA9 variants indicates they cause NDUFA9 misfolding and/or disruption of binding interfaces; fibroblasts from affected individuals show loss of fully assembled complex I with decreased steady-state NDUFA9 levels and/or complex I activity, with Arg360 identified as a mutational hotspot.\",\n      \"method\": \"Protein structural modelling, fibroblast complex I activity assays, steady-state protein level analysis\",\n      \"journal\": \"Brain communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2/3 — functional fibroblast data plus computational modelling, single study\",\n      \"pmids\": [\"41069424\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"YY1 transcription factor directly binds the NDUFA9 promoter and upregulates its expression in NSCLC cells; NDUFA9 positively regulates Akt-mTOR signaling, and its depletion reduces mTOR kinase activity and phosphorylation of Akt and S6K, linking NDUFA9-driven mitochondrial function to oncogenic signaling.\",\n      \"method\": \"ChIP/bioinformatics YY1-promoter validation, shRNA/KO in NSCLC cells with Akt-mTOR phosphorylation assays, xenograft in vivo studies\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2/3 — multiple in vitro and in vivo methods from a single lab; pathway placement by KD/OE with signaling readouts\",\n      \"pmids\": [\"42014681\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"NDUFA9 is an essential Q-module subunit of mitochondrial respiratory chain complex I that stabilizes the junction between the membrane and matrix arms during late-stage complex I assembly; loss-of-function mutations disrupt Q-module subassembly, abrogate complex I activity, and cause Leigh syndrome, while post-translational crotonylation of NDUFA9 enhances and acetylation inhibits its role in promoting mitochondrial respiration, and its expression is transcriptionally driven by YY1 with downstream coupling to Akt-mTOR signaling in cancer cells.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2008,\n      \"finding\": \"SIRT3, the mitochondrial NAD-dependent deacetylase, physically interacts with NDUFA9 (the 39-kDa Complex I subunit) and deacetylates multiple Complex I components; loss of SIRT3 increases acetylation of Complex I subunits and selectively inhibits Complex I activity, while exogenous SIRT3 augments Complex I activity, establishing NDUFA9 as a SIRT3 substrate/interactor that links protein acetylation to Complex I regulation.\",\n      \"method\": \"Co-immunoprecipitation of SIRT3 with NDUFA9; reconstitution with wild-type vs. deacetylase-deficient SIRT3 in Sirt3-/- MEFs; measurement of Complex I activity and ATP levels in knockout mice tissues\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP plus functional rescue with catalytic mutant, replicated across cell and animal models\",\n      \"pmids\": [\"18794531\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"A homozygous missense mutation in NDUFA9 (Arg321Pro) causes neonatally fatal Leigh syndrome with Complex I deficiency; lentiviral complementation with wild-type but not mutant NDUFA9 restored Complex I activity in patient fibroblasts, establishing NDUFA9 as an essential structural/functional subunit of Complex I whose integrity is required for Complex I activity.\",\n      \"method\": \"Homozygosity mapping; functional complementation with wild-type vs. mutant NDUFA9 via lentiviral transduction; Complex I enzyme activity assay in patient fibroblasts\",\n      \"journal\": \"Journal of medical genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function patient cells with defined biochemical phenotype rescued by wild-type but not mutant protein\",\n      \"pmids\": [\"22114105\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"TALEN-mediated knockout of NDUFA9 in HEK293T cells demonstrated that NDUFA9 is required for stabilizing the junction between the membrane arm and matrix arm of Complex I; cells lacking NDUFA9 accumulated a membrane arm subcomplex but lacked matrix arm marker subunits, and re-expression of NDUFA9 restored full Complex I assembly, identifying NDUFA9's role as a late assembly step critical for Complex I biogenesis.\",\n      \"method\": \"TALEN-mediated gene knockout; Blue-Native PAGE and immunoblotting of Complex I subcomplexes; galactose growth assay; rescue by re-expression of NDUFA9\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean biallelic KO with defined subcomplexes identified and rescued by re-expression; multiple orthogonal readouts\",\n      \"pmids\": [\"23223238\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Systematic knockout of all 31 accessory subunits of human Complex I confirmed NDUFA9 as strictly required for assembly of a functional Complex I; proteomic analysis showed that loss of NDUFA9 destabilizes subunits within the same Q-module structural module.\",\n      \"method\": \"CRISPR/Cas9 gene editing of each accessory subunit; quantitative proteomic analysis (TMT-based MS); Blue-Native PAGE\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genome-wide systematic KO screen with quantitative proteomics, strong mechanistic resolution at module level\",\n      \"pmids\": [\"27626371\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Cryo-EM structure of the human respiratory megacomplex I2III2IV2 enabled precise subunit assignment within Complex I, including NDUFA9 as part of the Q-module at the junction between the peripheral matrix arm and the membrane arm.\",\n      \"method\": \"Single-particle cryo-electron microscopy of purified human megacomplex I2III2IV2\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — high-resolution cryo-EM structure with individual subunit assignment\",\n      \"pmids\": [\"28844695\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Patient fibroblast studies with two different NDUFA9 missense variants showed that NDUFA9 is a Q-module subunit whose dysfunction causes accumulation of Q-module subassemblies; the more severe variant additionally caused P-module subassembly accumulation, demonstrating that the severity of the NDUFA9 variant correlates with the extent of Complex I assembly disruption. Lentiviral complementation with wild-type NDUFA9 rescued both Complex I deficiency and assembly defects.\",\n      \"method\": \"Patient fibroblast BN-PAGE complex I assembly analysis; lentiviral complementation with wild-type NDUFA9; exome sequencing for variant identification\",\n      \"journal\": \"Clinical genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — two independent patient alleles with assembly sub-complex characterization and functional rescue\",\n      \"pmids\": [\"28671271\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"NDUFA9 promotes browning of white adipocytes by enhancing mitochondrial Complex I activity, ATP synthesis, and mitochondrial respiration; crotonylation of NDUFA9 (induced by SAHA + sodium crotonate treatment) promotes white adipocyte browning, whereas acetylation of NDUFA9 inhibits this process, revealing a competition between these two PTMs as a regulatory switch for NDUFA9 function in adipocyte thermogenesis.\",\n      \"method\": \"NDUFA9 overexpression/knockdown in white adipocyte cell lines; SAHA + sodium crotonate or SAHA + sodium acetate treatment; measurement of mitochondrial Complex I activity, OCR, ATP production; in vivo fat browning mouse model\",\n      \"journal\": \"The international journal of biochemistry & cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2/3 — single lab with multiple functional readouts but PTM mechanism relies on pharmacological induction without site-specific mutagenesis\",\n      \"pmids\": [\"38657899\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Functional studies in fibroblasts from individuals with biallelic NDUFA9 variants showed loss of fully assembled Complex I, decreased steady-state NDUFA9 protein levels, and/or reduced Complex I activity; protein structural modelling indicated that pathogenic variants cause NDUFA9 misfolding and/or disruption of binding interfaces, with Arg360 identified as a mutational hotspot critical for protein stability/interactions.\",\n      \"method\": \"Patient fibroblast Complex I activity assay; BN-PAGE steady-state assembly analysis; in silico protein structural modelling of variant effects\",\n      \"journal\": \"Brain communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional fibroblast data from multiple patients; structural modelling is computational (Tier 4) but fibroblast biochemistry provides Tier 2 anchor\",\n      \"pmids\": [\"41069424\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"YY1 transcription factor directly binds the NDUFA9 promoter and drives its transcriptional upregulation in NSCLC; NDUFA9 depletion impairs mitochondrial Complex I activity, reduces oxygen consumption and ATP production, increases ROS, and suppresses Akt-mTOR signalling, while NDUFA9 overexpression enhances mitochondrial function and promotes Akt-mTOR activation, placing NDUFA9 as a positive regulator coupling mitochondrial metabolism to the Akt-mTOR pathway in cancer cells.\",\n      \"method\": \"ChIP and luciferase reporter assays for YY1-NDUFA9 promoter binding; shRNA/CRISPR KO and overexpression in NSCLC cells; measurement of OCR, Complex I activity, ATP, ROS, mitochondrial membrane potential, mtDNA; phospho-immunoblotting of Akt/S6K/mTOR; xenograft mouse tumour model\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods in single lab with in vivo validation; YY1 binding validated by ChIP\",\n      \"pmids\": [\"42014681\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"NDUFA9 is a Q-module accessory subunit of mitochondrial respiratory chain Complex I that is essential for stabilizing the junction between the membrane arm and matrix arm during late-stage Complex I assembly; it is a direct binding partner and substrate of the deacetylase SIRT3, whose activity promotes Complex I function, and its activity is further modulated by competing crotonylation (activating) and acetylation (inhibitory) modifications; transcriptionally, YY1 drives NDUFA9 expression, and NDUFA9 in turn sustains Akt-mTOR signalling by supporting mitochondrial ATP production and Complex I activity.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"NDUFA9 is an essential accessory subunit of mitochondrial respiratory chain complex I that functions within the Q-module to stabilize the junction between the membrane and matrix arms during late-stage complex I assembly [PMID:23223238, PMID:28671271]. Loss-of-function mutations, including the pathogenic R321P variant and a hotspot at Arg360, cause accumulation of incomplete complex I subcomplexes, abolish complex I enzymatic activity, and cause Leigh syndrome [PMID:22114105, PMID:28671271, PMID:41069424]. Post-translational modification regulates NDUFA9 function: crotonylation enhances complex I activity and mitochondrial respiration in adipocytes, whereas acetylation at competing sites inhibits these processes [PMID:38657899]. In non-small cell lung cancer cells, NDUFA9 expression is transcriptionally driven by YY1 and its activity couples to Akt-mTOR signaling, linking mitochondrial electron transport to oncogenic growth pathways [PMID:42014681].\",\n  \"teleology\": [\n    {\n      \"year\": 2011,\n      \"claim\": \"Establishing that NDUFA9 is functionally essential for complex I activity — a pathogenic missense mutation (R321P) was shown to cause complex I deficiency that was rescued by wild-type but not mutant NDUFA9, proving NDUFA9 is not merely a structural bystander but a required subunit.\",\n      \"evidence\": \"Homozygosity mapping in a patient with Leigh syndrome, lentiviral complementation with wild-type vs. mutant NDUFA9 in patient fibroblasts, complex I activity assay\",\n      \"pmids\": [\"22114105\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Mechanism by which R321P disrupts function was not resolved at the structural level\",\n        \"Whether NDUFA9 loss affects complex I assembly versus catalytic function was not distinguished\"\n      ]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Resolving NDUFA9's precise assembly role — knockout in human cells showed accumulation of a membrane-arm subcomplex lacking matrix-arm subunits, establishing that NDUFA9 stabilizes the junction between the membrane and matrix arms at a late assembly stage.\",\n      \"evidence\": \"TALEN-mediated knockout in HEK293T cells, blue native PAGE, complementation with wild-type re-expression\",\n      \"pmids\": [\"23223238\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Direct structural contacts between NDUFA9 and the interface subunits were not mapped\",\n        \"Whether NDUFA9 acts catalytically or purely structurally at the junction was not determined\"\n      ]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Placing NDUFA9 specifically within the Q-module assembly pathway — patient fibroblasts with distinct NDUFA9 variants accumulated Q-module and P-module subassemblies, and complementation rescued both activity and assembly, defining NDUFA9 as a Q-module subunit essential for its biogenesis.\",\n      \"evidence\": \"Blue native PAGE assembly analysis in fibroblasts from two independent patients, lentiviral wild-type NDUFA9 complementation\",\n      \"pmids\": [\"28671271\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Order of NDUFA9 incorporation relative to other Q-module subunits was not established\",\n        \"Whether partial Q-module subcomplexes retain any residual electron transfer capacity was not tested\"\n      ]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Revealing post-translational regulation of NDUFA9 — crotonylation and acetylation compete at the same lysine residues, with crotonylation enhancing and acetylation inhibiting complex I activity and mitochondrial respiration, providing the first evidence that NDUFA9 function is dynamically tunable.\",\n      \"evidence\": \"Overexpression with SAHA/crotonate or SAHA/acetate treatment in adipocytes, complex I activity assay, oxygen consumption rate measurement, white fat browning mouse model\",\n      \"pmids\": [\"38657899\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Specific lysine sites responsible for the functional switch were not identified by site-directed mutagenesis\",\n        \"Whether crotonylation/acetylation affects NDUFA9 assembly into complex I or catalytic efficiency of assembled complex was not distinguished\",\n        \"Findings from a single laboratory await independent confirmation\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Defining a mutational hotspot and structural basis for disease — protein modelling of multiple disease-associated variants identified Arg360 as a recurrent mutation site that disrupts NDUFA9 folding or binding interfaces, with patient fibroblasts confirming loss of assembled complex I.\",\n      \"evidence\": \"Protein structural modelling combined with fibroblast complex I activity and steady-state protein level analysis\",\n      \"pmids\": [\"41069424\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Structural predictions were not validated by experimental structures of mutant NDUFA9\",\n        \"Genotype-phenotype correlation across the full mutation spectrum remains incomplete\"\n      ]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Linking NDUFA9 to transcriptional control and oncogenic signaling — YY1 was shown to directly drive NDUFA9 transcription, and NDUFA9 depletion reduced Akt-mTOR pathway activity, connecting mitochondrial complex I function to growth signaling in cancer cells.\",\n      \"evidence\": \"ChIP for YY1 at the NDUFA9 promoter, shRNA/KO in NSCLC cells with phospho-Akt and phospho-S6K readouts, xenograft studies\",\n      \"pmids\": [\"42014681\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether Akt-mTOR activation is a direct consequence of NDUFA9-dependent bioenergetics or involves a specific signaling intermediate is unknown\",\n        \"Generalizability beyond NSCLC to other cancer contexts has not been tested\",\n        \"Single-lab finding awaits independent replication\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Outstanding question: the atomic-resolution mechanism by which NDUFA9 stabilizes the membrane–matrix arm junction and how post-translational modifications alter this function in assembled complex I remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No high-resolution structure of NDUFA9 mutants within complex I is available\",\n        \"Site-specific mutagenesis of crotonylation/acetylation sites has not been performed\",\n        \"Whether NDUFA9 has any function independent of complex I has not been explored\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [0, 2]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [0, 1, 2, 3]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [0, 1, 2, 3]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [1, 2, 4]}\n    ],\n    \"complexes\": [\"Complex I (NADH:ubiquinone oxidoreductase)\"],\n    \"partners\": [\"YY1\"],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"NDUFA9 is an accessory subunit of mitochondrial respiratory chain Complex I that occupies the Q-module at the junction between the peripheral matrix arm and the membrane arm, where it is indispensable for late-stage Complex I assembly and activity. TALEN- and CRISPR-mediated knockout studies show that loss of NDUFA9 causes accumulation of incomplete membrane-arm subcomplexes while preventing incorporation of matrix-arm subunits, and re-expression rescues full Complex I assembly and oxidative phosphorylation [PMID:23223238, PMID:27626371]. NDUFA9 is a direct substrate of the mitochondrial deacetylase SIRT3, and its activity is further modulated by competing crotonylation (activating) and acetylation (inhibitory) post-translational modifications that tune Complex I function in contexts such as adipocyte thermogenesis [PMID:18794531, PMID:38657899]. Biallelic loss-of-function mutations in NDUFA9 cause Leigh syndrome with isolated Complex I deficiency [PMID:22114105, PMID:28671271].\",\n  \"teleology\": [\n    {\n      \"year\": 2008,\n      \"claim\": \"Identifying SIRT3 as a direct NDUFA9 interactor and deacetylase established that reversible lysine acetylation regulates Complex I activity, linking NAD⁺-dependent signalling to oxidative phosphorylation.\",\n      \"evidence\": \"Co-immunoprecipitation of SIRT3 with NDUFA9; Complex I activity and ATP measurements in Sirt3-knockout MEFs and tissues with wild-type vs. catalytically dead SIRT3 rescue\",\n      \"pmids\": [\"18794531\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Specific NDUFA9 lysine residues targeted by SIRT3 were not mapped\",\n        \"Whether SIRT3-mediated deacetylation affects Complex I assembly or only catalytic activity was not resolved\"\n      ]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Discovery that a homozygous NDUFA9 missense variant (Arg321Pro) causes fatal Leigh syndrome with isolated Complex I deficiency proved that NDUFA9 integrity is essential for Complex I function in humans.\",\n      \"evidence\": \"Homozygosity mapping in a consanguineous family; lentiviral wild-type vs. mutant NDUFA9 complementation in patient fibroblasts with Complex I activity rescue\",\n      \"pmids\": [\"22114105\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Mechanism by which the Arg321Pro substitution disrupts Complex I was not determined at structural level\",\n        \"Whether residual Complex I assembly persists in patient cells was not characterized\"\n      ]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"TALEN-mediated knockout revealed that NDUFA9 acts at a late assembly step, stabilizing the junction between the membrane and matrix arms of Complex I — cells lacking NDUFA9 accumulate an incomplete membrane-arm subcomplex.\",\n      \"evidence\": \"Biallelic NDUFA9 KO in HEK293T; BN-PAGE subcomplex profiling; galactose growth assay; rescue by NDUFA9 re-expression\",\n      \"pmids\": [\"23223238\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"The precise molecular contacts through which NDUFA9 bridges the two arms were not resolved\",\n        \"Whether NDUFA9 loss also affects supercomplex formation was not tested\"\n      ]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"A systematic CRISPR screen of all 31 accessory subunits confirmed NDUFA9 as strictly essential and assigned it to the Q-module, showing that its loss destabilises co-modular subunits.\",\n      \"evidence\": \"CRISPR/Cas9 KO of each accessory subunit in HEK293T; TMT-based quantitative proteomics; BN-PAGE\",\n      \"pmids\": [\"27626371\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Order of NDUFA9 incorporation relative to other Q-module subunits during assembly was not resolved\"\n      ]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"High-resolution cryo-EM of the human respiratory megacomplex provided the first atomic-level view of NDUFA9 within the Q-module, confirming its position at the membrane-matrix arm interface and enabling rationalisation of disease mutations.\",\n      \"evidence\": \"Single-particle cryo-EM of purified human megacomplex I₂III₂IV₂\",\n      \"pmids\": [\"28844695\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Dynamic conformational changes of NDUFA9 during the catalytic cycle (A/D transition) were not captured\"\n      ]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Analysis of two additional patient NDUFA9 alleles demonstrated that variant severity correlates with the degree of Complex I assembly disruption, extending the genotype-phenotype relationship and confirming Q-module subassembly accumulation as a diagnostic signature.\",\n      \"evidence\": \"BN-PAGE assembly profiling and lentiviral rescue in fibroblasts from patients with two distinct NDUFA9 missense variants\",\n      \"pmids\": [\"28671271\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Threshold level of residual NDUFA9 function compatible with survival was not defined\"\n      ]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Demonstration that crotonylation activates and acetylation inhibits NDUFA9 function in adipocytes revealed a PTM-based switch controlling Complex I-dependent thermogenesis, extending the regulatory framework beyond SIRT3-mediated deacetylation.\",\n      \"evidence\": \"NDUFA9 overexpression/knockdown in white adipocytes; pharmacological induction of crotonylation vs. acetylation; OCR, ATP, and Complex I activity measurements; in vivo browning model\",\n      \"pmids\": [\"38657899\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Specific crotonylated and acetylated lysine sites on NDUFA9 were not identified by site-directed mutagenesis\",\n        \"Whether these PTMs alter NDUFA9 assembly into Complex I or only its catalytic contribution is unknown\",\n        \"Results rely on pharmacological PTM induction rather than site-specific modification\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Expanded patient cohort analysis with structural modelling identified Arg360 as a mutational hotspot and showed that pathogenic variants cause NDUFA9 misfolding or disruption of inter-subunit binding interfaces, providing a structural rationale for disease severity.\",\n      \"evidence\": \"Patient fibroblast BN-PAGE and Complex I activity assays; in silico protein structural modelling of multiple NDUFA9 variants\",\n      \"pmids\": [\"41069424\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Structural predictions have not been validated by experimental structure determination of mutant forms\",\n        \"Functional rescue with site-directed mutants of Arg360 was not performed\"\n      ]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Identification of YY1 as a direct transcriptional activator of NDUFA9 and demonstration that NDUFA9 depletion suppresses Akt-mTOR signalling placed NDUFA9 as a node coupling mitochondrial ATP output to growth-factor signalling in cancer cells.\",\n      \"evidence\": \"ChIP and luciferase reporter assays for YY1 binding; NDUFA9 KD/KO and overexpression in NSCLC lines; OCR, ATP, ROS, phospho-Akt/S6K immunoblotting; xenograft model\",\n      \"pmids\": [\"42014681\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether YY1-driven NDUFA9 expression is relevant outside NSCLC contexts is untested\",\n        \"Whether the Akt-mTOR effect is specific to NDUFA9 or a general consequence of Complex I deficiency is not distinguished\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key open questions include the identity and functional impact of specific NDUFA9 lysine residues modified by SIRT3, crotonylation, and acetylation; the conformational dynamics of NDUFA9 during the active/deactive transition of Complex I; and whether NDUFA9 has roles beyond Complex I (e.g. in supercomplex organisation or signalling).\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No site-specific mutagenesis of individual PTM sites has been performed\",\n        \"Conformational dynamics of NDUFA9 during the A/D transition remain unresolved\",\n        \"Potential scaffolding or signalling functions independent of Complex I catalysis have not been investigated\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [2, 3, 4, 5]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [0, 1, 2, 3, 4, 5, 6, 7, 8]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [0, 1, 2, 3, 6, 8]},\n      {\"term_id\": \"R-HSA-1852241\", \"supporting_discovery_ids\": [2, 3, 5]}\n    ],\n    \"complexes\": [\n      \"Complex I (NADH:ubiquinone oxidoreductase)\",\n      \"Respiratory megacomplex I2III2IV2\"\n    ],\n    \"partners\": [\n      \"SIRT3\",\n      \"YY1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}